Vera Therapeutics, Inc. (VERA)
VERA Stock Price Chart
Explore Vera Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze VERA price movements and trends.
VERA Company Profile
Discover essential business fundamentals and corporate details for Vera Therapeutics, Inc. (VERA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 May 2021
Employees
152.00
Website
https://veratx.comCEO
Marshall W. Fordyce
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
VERA Financial Timeline
Browse a chronological timeline of Vera Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$1.14.
Earnings released on 5 Aug 2025
EPS came in at -$1.20 falling short of the estimated -$0.82 by -46.34%.
Earnings released on 6 May 2025
EPS came in at -$0.81 falling short of the estimated -$0.75 by -8.00%.
Earnings released on 26 Feb 2025
EPS came in at -$0.72 surpassing the estimated -$0.83 by +13.25%.
Earnings released on 7 Nov 2024
EPS came in at -$0.85 falling short of the estimated -$0.69 by -23.19%.
Earnings released on 8 Aug 2024
EPS came in at -$0.62 falling short of the estimated -$0.58 by -6.90%.
Earnings released on 9 May 2024
EPS came in at -$0.56 falling short of the estimated -$0.53 by -5.66%.
Earnings released on 20 Mar 2024
EPS came in at -$0.58 falling short of the estimated -$0.53 by -9.43%.
Earnings released on 9 Nov 2023
EPS came in at -$0.45 surpassing the estimated -$0.50 by +10.00%.
Earnings released on 10 Aug 2023
EPS came in at -$0.46 surpassing the estimated -$0.69 by +33.33%.
Earnings released on 11 May 2023
EPS came in at -$0.80 falling short of the estimated -$0.60 by -33.33%.
Earnings released on 28 Mar 2023
EPS came in at -$1.19 falling short of the estimated -$0.93 by -27.96%.
Earnings released on 9 Nov 2022
EPS came in at -$0.91 falling short of the estimated -$0.72 by -26.39%.
Earnings released on 10 Aug 2022
EPS came in at -$0.55 surpassing the estimated -$0.72 by +23.61%.
Earnings released on 16 May 2022
EPS came in at -$0.71 falling short of the estimated -$0.67 by -5.97%.
Earnings released on 24 Mar 2022
EPS came in at -$0.79 falling short of the estimated -$0.49 by -61.22%.
Earnings released on 10 Nov 2021
EPS came in at -$0.36 surpassing the estimated -$0.60 by +40.00%.
Earnings released on 16 Aug 2021
EPS came in at -$0.33 surpassing the estimated -$0.39 by +15.38%.
Earnings released on 24 Jun 2021
EPS came in at -$12.23 falling short of the estimated -$1.94 by -530.41%.
Earnings released on 23 Apr 2021
EPS came in at -$2.09 .
Earnings released on 30 Sept 2020
EPS came in at -$1.09 .
VERA Stock Performance
Access detailed VERA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.